Access to anti-retroviral drugs, female in Peru
Peru: Access to anti-retroviral drugs, female was 86.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Peru, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Peru recorded 86.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 7.5% on the previous year and up 45.8% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Peru peaked at 86.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Peru 47th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Peru, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 2.0% | — |
| 2003 | 4.0% | +100.0% |
| 2004 | 3.0% | -25.0% |
| 2005 | 8.0% | +166.7% |
| 2006 | 12.0% | +50.0% |
| 2007 | 25.0% | +108.3% |
| 2008 | 29.0% | +16.0% |
| 2009 | 40.0% | +37.9% |
| 2010 | 45.0% | +12.5% |
| 2011 | 45.0% | +0.0% |
| 2012 | 55.0% | +22.2% |
| 2013 | 54.0% | -1.8% |
| 2014 | 59.0% | +9.3% |
| 2015 | 64.0% | +8.5% |
| 2016 | 70.0% | +9.4% |
| 2017 | 66.0% | -5.7% |
| 2018 | 67.0% | +1.5% |
| 2019 | 71.0% | +6.0% |
| 2020 | 69.0% | -2.8% |
| 2021 | 74.0% | +7.2% |
| 2022 | 81.0% | +9.5% |
| 2023 | 80.0% | -1.2% |
| 2024 | 86.0% | +7.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 12.3% | 0.0% | 40.0% | 10 |
| 2010s | 59.6% | 45.0% | 71.0% | 10 |
| 2020s | 78.0% | 69.0% | 86.0% | 5 |
Countries ranked near Peru
- 44 Uganda 88.0% compare
- 45 Australia 87.0% compare
- 45 Luxembourg 87.0% compare
- 47 Iceland 86.0% compare
- 49 Mozambique 85.0% compare
- 50 Côte d'Ivoire 84.0% compare
- 50 Singapore 84.0% compare
- 50 South Africa 84.0% compare
More gender data for Peru
- Child population (UN estimates and projections) 7,988 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.3909 % change on previous year (2030)
- Population 28,205 (2030)
- Working-age population (UN estimates and projections) 28,205 (2030)
- Age population, age 00, female, interpolated 261,493 (2025)
- Age population, age 00, male, interpolated 271,554 (2025)
- Age population, age 01, female, interpolated 262,030 (2025)
- Age population, age 01, male, interpolated 271,974 (2025)
- Age population, age 02, female, interpolated 262,425 (2025)
- Age population, age 02, male, interpolated 272,367 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Peru?
- Access to anti-retroviral drugs, female in Peru was 86.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Peru?
- The highest recorded value was 86.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Peru?
- The lowest recorded value was 0.0% in 2000.
- How does Peru rank for access to anti-retroviral drugs, female?
- Peru ranks 47th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Peru?
- Over the last ten years it is up 45.8%. The long-run trend across the full record is volatile.
- Where does this Peru data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.